Workforce reductions announced at ImmunityBio in Dunkirk | News, Sports, Jobs


WATCH Photo by Braden Carmen ImmunityBio took over the former Athenex plant in February.

DUNKIRK — Citing “building needs” In what was described a few years ago as a state-of-the-art facility, ImmunityBio has confirmed that there will be fewer workers at its Dunkirk plant for a year and a half.

However, at least two sources, including one who said he was a worker, said the company fired all but a handful of employees without notice after their meeting on Thursday.

News of the employee withdrawal came after a “thorough examination” of the publicly funded facility at 3805 Lake Shore Drive, the lease of which was acquired by ImmunityBio in February of this year from Athenex.

A spokeswoman for the California Society for Clinical-Stage Immunotherapy said it has been determined that the plant “has construction requirements that may take approximately 12 to 18 months to allow the facility to be used as intended.”

She added, in a statement to the OBSERVATEUR, “For this reason, we will need fewer employees during the construction period. That said, we remain committed to the Dunkirk region and the large-scale manufacturing plant.

An employee, who wished to remain anonymous, said they gathered inside the factory cafeteria on Thursday and informed the facility that work was needed that could last more than a month. year. The employee estimated that up to 40 people had been laid off in various departments, including plant services, microbiology and office workers. He also said employees were told on Thursday they could reapply for their jobs once the upgrades were completed.



Today’s breaking news and more to your inbox







Michael A. Bynum